Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA yield high or low?
The EBITDA yield of 3.57% is in line with its estimated 1-year average of 3.47%, around the middle of its estimated 1-year range (3.29%–3.72%).
As of 2026-10-06T16:57:23.870Z.
Calculation as of: 2026-10-06T16:57:23.870Z.
Quote observation: 2026-10-06T16:55:19.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 757805bafeebc6dd018a704dcae2ac70006cc574d7bdbc7e38b059e75a8ad8a2
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EBITDA YIELD
3.57%
EBITDA YIELD AVG TTM
N/A
EBITDA YIELD AVG 3Y
N/A
EBITDA YIELD AVG 5Y
N/A
EBITDA YIELD AVG 10Y
N/A
EBITDA YIELD AVG 15Y
N/A
EBITDA YIELD AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
6.35%
median of 205 covered companies
CURRENT VS SECTOR MEDIAN
-43.78%
vs the sector median at left
Lumexa Imaging Holdings, Inc. Common Stock
Market Cap
$1.03B
EBITDA Yield
3.57%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.03B
EBITDA Yield
N/A
TTM Avg
3.55%
3Y Avg
3.10%
5Y Avg
3.10%
Market Cap
$1.04B
EBITDA Yield
N/A
TTM Avg
50.22%
3Y Avg
50.22%
5Y Avg
50.22%
Market Cap
$1.04B
EBITDA Yield
28.22%
TTM Avg
14.07%
3Y Avg
7.65%
5Y Avg
6.82%
Market Cap
$991.81M
EBITDA Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EBITDA YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI) | $1.03B | 3.57% | N/A | N/A | N/A |
| Castle Biosciences, Inc. (CSTL)vs › | $1.03B | N/A | 3.55% | 3.10% | 3.10% |
| Immatics N.V. (IMTX)vs › | $1.03B | N/A | 5.69% | 5.69% | 5.69% |
| Janux Therapeutics, Inc. (JANX)vs › | $1.03B | N/A | N/A | N/A | N/A |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $1.04B | N/A | 50.22% | 50.22% | 50.22% |
| Integra LifeSciences Holdings Corporation (IART)vs › | $1.04B | 28.22% | 14.07% | 7.65% | 6.82% |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $1.00B | N/A | N/A | N/A | N/A |
| Teladoc Health, Inc. (TDOC)vs › | $1.05B | 7.73% | 4.52% | 2.41% | 2.41% |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $991.81M | N/A | N/A | N/A | N/A |
| Pacira BioSciences, Inc. (PCRX)vs › | $982.98M | 8.71% | 9.22% | 7.66% | 6.32% |
EBITDA Yield = TTM EBITDA / Enterprise Value
EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA YIELD |
|---|---|
| 2026-10-05 | 3.55% |
| 2026-10-02 | 3.63% |
| 2026-10-01 | 3.68% |
| 2026-09-30 | 3.65% |
| 2026-09-29 | 3.65% |
| 2026-09-28 | 3.67% |
| 2026-09-25 | 3.66% |
| 2026-09-24 | 3.72% |
| 2026-09-23 | 3.67% |
| 2026-09-22 | 3.60% |
| 2026-09-21 | 3.57% |
| 2026-09-18 | 3.50% |
| 2026-09-17 | 3.43% |
| 2026-09-16 | 3.41% |
| 2026-09-15 | 3.39% |
| 2026-09-14 | 3.45% |
| 2026-09-11 | 3.43% |
| 2026-09-10 | 3.48% |
| 2026-09-09 | 3.47% |
| 2026-09-08 | 3.42% |
| 2026-09-04 | 3.32% |
| 2026-09-03 | 3.37% |
| 2026-09-02 | 3.39% |
| 2026-09-01 | 3.41% |
| 2026-08-31 | 3.40% |
| 2026-08-28 | 3.43% |
| 2026-08-27 | 3.39% |
| 2026-08-26 | 3.36% |
| 2026-08-25 | 3.34% |
| 2026-08-24 | 3.37% |
| 2026-08-21 | 3.29% |
| 2026-08-20 | 3.40% |
| 2026-08-19 | 3.37% |
| 2026-08-18 | 3.35% |
| 2026-08-17 | 3.38% |
| 2026-08-14 | 3.35% |
